User profiles for N. Stransky
Nicolas StranskyCaris Life Sciences Verified email at carisls.com Cited by 48116 |
[HTML][HTML] Targeting cancer with kinase inhibitors
S Gross, R Rahal, N Stransky… - The Journal of …, 2015 - Am Soc Clin Investig
… These early compounds bound in the ATP-binding pocket residing in the cleft between
the N- and C-lobes of kinases. Even today, the majority of kinase inhibitors bind via a similar …
the N- and C-lobes of kinases. Even today, the majority of kinase inhibitors bind via a similar …
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
J Barretina, G Caponigro, N Stransky, K Venkatesan… - Nature, 2012 - nature.com
… Mean true positive rate and standard deviation (n = 5) are shown when models are built …
between cell lines derived from haematopoietic (n = 61) and solid tumours (n = 387). The middle …
between cell lines derived from haematopoietic (n = 61) and solid tumours (n = 387). The middle …
[HTML][HTML] A landscape of driver mutations in melanoma
…, A Sivachenko, D Voet, G Saksena, N Stransky… - Cell, 2012 - cell.com
Despite recent insights into melanoma genetics, systematic surveys for driver mutations are
challenged by an abundance of passenger mutations caused by carcinogenic UV light …
challenged by an abundance of passenger mutations caused by carcinogenic UV light …
[PDF][PDF] Comprehensive and integrative genomic characterization of hepatocellular carcinoma
Liver cancer has the second highest worldwide cancer mortality rate and has limited
therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome …
therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome …
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Major international projects are underway that are aimed at creating a comprehensive catalogue
of all the genes responsible for the initiation and progression of cancer 1 , 2 , 3 , 4 , 5 , 6 …
of all the genes responsible for the initiation and progression of cancer 1 , 2 , 3 , 4 , 5 , 6 …
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Prostate cancer is the second most common cancer in men worldwide and causes over
250,000 deaths each year 1 . Overtreatment of indolent disease also results in significant …
250,000 deaths each year 1 . Overtreatment of indolent disease also results in significant …
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
… pre-injection cells compared to tumours, for n = 5 tumours for the transporter pool and n =
12 tumours for the metabolic enzyme pool, or to cells at day 25–28 for n = 4 in vitro cultures. P …
12 tumours for the metabolic enzyme pool, or to cells at day 25–28 for n = 4 in vitro cultures. P …
The mutational landscape of head and neck squamous cell carcinoma
N Stransky, AM Egloff, AD Tward, AD Kostic… - science, 2011 - science.org
Head and neck squamous cell carcinoma (HNSCC) is a common, morbid, and frequently
lethal malignancy. To uncover its mutational spectrum, we analyzed whole-exome sequencing …
lethal malignancy. To uncover its mutational spectrum, we analyzed whole-exome sequencing …
[HTML][HTML] Sequence analysis of mutations and translocations across breast cancer subtypes
Breast carcinoma is the leading cause of cancer-related mortality in women worldwide, with
an estimated 1.38 million new cases and 458,000 deaths in 2008 alone 1 . This malignancy …
an estimated 1.38 million new cases and 458,000 deaths in 2008 alone 1 . This malignancy …
Next-generation characterization of the cancer cell line encyclopedia
… r = n i /(n i + n s ). We required each exon ratio to be supported by at least 10 reads (n i + n s
… We used log(50 + N), in which N is the nSolver normalized value to reduce the effect of the …
… We used log(50 + N), in which N is the nSolver normalized value to reduce the effect of the …